Liste des publications

Toutes les publications des équipes du C3M.

Exporter en CSV
Atherosclerosis Calcification: Focus on Lipoproteins.

Auteurs Neels JG, Leftheriotis G, Chinetti G

Metabolites Mar 2023

Critical Overview on Endocrine Disruptors in Diabetes Mellitus.

Auteurs Hinault C, Caroli-Bosc P, Bost F, Chevalier N

International journal of molecular sciences Mar 2023

Production of CRISPRi-engineered primary human mammary epithelial cells with baboon envelope pseudotyped lentiviral vectors.

Auteurs Pastor S, Wicinski J, Charafe-Jauffret E, Verhoeyen E, Guittard G, Ginestier C

STAR protocols Feb 2023

Impaired Function of Solute Carrier Family 19 Leads to Low Folate Levels and Lipid Droplet Accumulation in Hepatocytes.

Auteurs Cano A, Vazquez-Chantada M, Conde-Vancells J, Gonzalez-Lahera A, Mosen-Ansorena D, Blanco FJ, Clément K, Aron-Wisnewsky J, Tran A, Gual P, García-Monzón C, Caballería J, Castro A, Martínez-Chantar ML, Mato JM, Zhu H, Finnell RH, Aransay AM

Biomedicines Feb 2023

Caspase Inhibition Modulates Monocyte-Derived Macrophage Polarization in Damaged Tissues.

Auteurs Solier S, Mondini M, Meziani L, Jacquel A, Lacout C, Berghe TV, Julé Y, Martinou JC, Pierron G, Rivière J, Deloger M, Dupuy C, Slama-Schwok A, Droin N, Vandenabeele P, Auberger P, Deutsch E, El-Benna J, Dang PM, Solary E

International journal of molecular sciences Feb 2023

[Medulloblastoma: The latest major advances].

Auteurs Contenti J, Bost F, Mazure NM

Bulletin du cancer Feb 2023

Spatial patterns of the cap-binding complex eIF4F in human melanoma cells.

Auteurs Tang X, Pu Y, Peng H, Li K, Faouzi S, Lu T, Pu D, Cerezo M, Xu J, Li L, Robert C, Shen S

Computational and structural biotechnology journal Feb 2023

From normal hematopoiesis to malignancies: Highlights from the 2021 Meeting of the Club Hematopoiesis and Oncogenesis.

Auteurs Troadec MB, Porteu F, Arcangeli ML, Foudi A, Bluteau D, De Sepulveda P, Guillouf C, Mazure NM, Meggetto F, Brunet De La Grange P, Broccardo C

Bulletin du cancer Feb 2023

Novel Therapeutic Targets in Melanoma.

Auteurs Cerezo M, Rocchi S

Cancers Feb 2023

Repurposing the Bis-Biguanide Alexidine in Combination with Tyrosine Kinase Inhibitors to Eliminate Leukemic Stem/Progenitor Cells in Chronic Myeloid Leukemia.

Auteurs Muselli F, Mourgues L, Rochet N, Nebout M, Guerci A, Verhoeyen E, Krug A, Legros L, Peyron JF, Mary D

Cancers Feb 2023